AmniSure®
International
|
Clinicians on AmniSure
American Society of Maternal Fetal Medicine
AmniSure® Roundtable Webcasts 2007
"I have not had a single case where I was concerned about the accuracy of the test. Every time is has been used; it seems to give the correct result....AmniSure® seems to have promise to become the next gold standard for the diagnosis of rupture of membranes."
Excerpt from AmniSure® Roundtable with Dr. Richard Porreco, MD, Director of Maternal Fetal Medicine at Presbyterian St. Luke’s Medical Center in Denver, Colorado.and Dr. Andrew C. Combs, MD, PhD, Chairman of Ob/Gyn at Good Samaritan Hospital in San Jose, California.
View video and read complete transcript.
"The advantage of this [AmniSure®] test; [is that] it is much more objective, and also there is an enormous distinction between the concentration of this protein in the amniotic fluid, and the cervical vaginal discharge. The difference is about 1,000 to 10,000 fold, so that even a small leakage of amniotic fluid into the vagina will cause a large amount of this protein to be present."
Excerpt from Roundtable: Dr. Errol R. Norwitz, Yale University School of Medicine, New Haven CT, interviewed by Alix Boyle, OBGYN.net interviews
View video and read complete transcript.
|
